Theravance Biopharma Reaches Analyst Target Price
5/5 13:16
In recent trading, shares of Theravance Biopharma, Inc. (Symbol: TBPH) have crossed above the average analyst 12-month target price of $16.83, changing hands for $16.91/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgr...